Medtronic (MDT) FCF Margin (2014 - 2026)

Medtronic has disclosed FCF Margin across 13 years of filings, most recently posting 25.51% for Q1 2026.

• FCF Margin for Q1 2026 came in at 25.51%, up 23.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 15.25% (down 122.0% YoY), and the FY2025 annual result was 15.46%, down 61.0% from the prior year.
• FCF Margin came in at 25.51% for Q1 2026 at Medtronic, up from 5.1% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 27.37% in Q2 2024 to a low of 2.51% in Q4 2023.
• The 5-year median for FCF Margin is 16.07% (2023), against an average of 15.51%.
• Across the five-year window, FCF Margin tumbled 1119 bps in 2022 and surged 1023 bps in 2024, its largest moves.
• Medtronic's FCF Margin stood at 7.9% in 2022, then slumped by 68 bps to 2.51% in 2023, then surged by 163 bps to 6.59% in 2024, then fell by 23 bps to 5.1% in 2025, then soared by 400 bps to 25.51% in 2026.
• The last three FCF Margin figures came in at 25.51% (Q1 2026), 5.1% (Q4 2025), and 6.81% (Q3 2025), per Business Quant data.